Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2026-02-01 @ 12:47 AM
Study NCT ID:
NCT05942768
Status:
COMPLETED
Last Update Posted:
2023-07-12
First Post:
2023-07-04
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Anti-PD-1 Antibody Plus Regorafenib in Refractory Microsatellite Stable Metastatic Colorectal Cancer
Sponsor:
Hunan Cancer Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
REGOPD-1-Hunan
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None